Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and crohn’s disease

HIGHLIGHTS

• who: Michael Logan from the of Medical, and, University of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow , ER, UK have published the article: Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohnu2019s disease, in the Journal: (JOURNAL)
• what: This study evaluated intestinal fatty acid binding protein (iFABP) a potential biomarker of small bowel damage in children with coeliac disease and Crohn`s disease.
• how: Regarding the influence of disease location the results are in accordance with the largest study to date which explored the utility of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.